VANCOUVER, British Columbia and PALO ALTO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- via IBN --  Fifty1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), together with its commercial partner BioSpark AI Technologies Inc., is announcing a major milestone in its AI-driven drug repurposing and functional medicine initiative. The joint effort has successfully transformed over 10,000 unstructured case reports into a fully structured, queryable database of more than 2,000 real-world patient treatment-outco ...